12.35
                                            前日終値:
              $12.75
            開ける:
              $12.74
            24時間の取引高:
                109.93K
            Relative Volume:
              0.97
            時価総額:
                $213.98M
            収益:
              $6.67M
            当期純損益:
              $-47.55M
            株価収益率:
              -8.2333
            EPS:
                -1.5
            ネットキャッシュフロー:
                $-17.44M
            1週間 パフォーマンス:
              -5.00%
            1か月 パフォーマンス:
              +5.38%
            6か月 パフォーマンス:
                +2,315%
            1年 パフォーマンス:
              +2,315%
            Crescent Biopharma Inc Stock (CBIO) Company Profile
CBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CBIO
                            
                             
                        Crescent Biopharma Inc 
                           | 
                    12.35 | 213.98M | 6.67M | -47.55M | -17.44M | -1.50 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Crescent Biopharma Inc Stock (CBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 | 
|---|---|---|---|
| 2025-08-25 | 開始されました | Jefferies | Buy | 
| 2025-08-11 | 開始されました | H.C. Wainwright | Buy | 
| 2025-07-14 | 開始されました | Wedbush | Outperform | 
| 2025-06-25 | 開始されました | Stifel | Buy | 
| 2025-03-21 | 開始されました | Cantor Fitzgerald | Overweight | 
| 2025-03-11 | 開始されました | Noble Capital Markets | Outperform | 
| 2024-07-26 | ダウングレード | TD Cowen | Buy → Hold | 
| 2023-12-22 | 開始されました | CapitalOne | Overweight | 
| 2021-11-12 | アップグレード | Jefferies | Hold → Buy | 
| 2021-04-29 | 再開されました | Stephens | Overweight | 
| 2021-02-10 | 開始されました | Piper Sandler | Overweight | 
| 2020-05-21 | 開始されました | Raymond James | Outperform | 
| 2019-11-14 | 開始されました | ROTH Capital | Buy | 
| 2019-08-05 | ダウングレード | Jefferies | Buy → Hold | 
| 2019-08-05 | ダウングレード | Piper Jaffray | Overweight → Neutral | 
| 2019-08-05 | ダウングレード | SunTrust | Buy → Hold | 
| 2019-04-12 | 開始されました | Piper Jaffray | Overweight | 
| 2019-01-04 | 開始されました | Oppenheimer | Outperform | 
| 2018-12-18 | 開始されました | H.C. Wainwright | Buy | 
| 2018-02-12 | 繰り返されました | B. Riley FBR, Inc. | Buy | 
| 2018-02-09 | 繰り返されました | Chardan Capital Markets | Buy | 
| 2017-12-08 | 開始されました | B. Riley FBR, Inc. | Buy | 
| 2017-06-12 | 開始されました | Chardan Capital Markets | Buy | 
| 2017-06-06 | 開始されました | Ladenburg Thalmann | Buy | 
| 2016-07-26 | 開始されました | SunTrust | Buy | 
| 2016-06-30 | 開始されました | Rodman & Renshaw | Buy | 
| 2015-03-17 | 繰り返されました | Stifel | Buy | 
                    すべてを表示
                    
                  
                Crescent Biopharma Inc (CBIO) 最新ニュース
Crescent Biopharma (NASDAQ:CBIO) Stock Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
What market sentiment indicators show for Crescent Biopharma Inc. (GKO0) stockEarnings Recap Report & Long-Term Safe Investment Ideas - newser.com
What valuation ratios show for Crescent Biopharma Inc. (GKO0) stockM&A Rumor & AI Enhanced Market Trend Forecasts - newser.com
Crescent BiopharmaLighting The Path To The Next Wave Of Cancer Therapies? - RTTNews
Is Crescent Biopharma Inc. (GKO0) stock a top hedge fund pickTrade Volume Summary & Verified Swing Trading Watchlist - newser.com
Is Crescent Biopharma Inc. (GKO0) stock expanding market penetration2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Will Crescent Biopharma Inc. (GKO0) stock top growth indexes2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Retail Surge: Will Crescent Biopharma Inc. (GKO0) stock beat value stocksJuly 2025 Price Swings & Reliable Price Breakout Alerts - Trung tâm Dự báo KTTV quốc gia
Moving Averages: Can Crescent Biopharma Inc. (GKO0) stock stage a strong rebound this quarter2025 Performance Recap & Stepwise Trade Signal Implementation - Trung tâm Dự báo KTTV quốc gia
TANG CAPITAL MANAGEMENT LLC Increases Stake in Crescent Biopharm - GuruFocus
GlycoMimetics skyrockets on buyout deal - MSN
Crescent Biopharma (NASDAQ:CBIO) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Will Crescent Biopharma Inc. (GKO0) stock beat value stocksJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
GlycoMimetics adjusts merger terms with Crescent Biopharma - MSN
Will Crescent Biopharma Inc. (GKO0) stock benefit from Fed rate cutsJuly 2025 Update & Safe Entry Zone Identification - newser.com
Short Interest in Crescent Biopharma, Inc. (NASDAQ:CBIO) Grows By 103.8% - MarketBeat
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives $25.60 Consensus Target Price from Analysts - Defense World
Will Crescent Biopharma Inc. (GKO0) stock hit Wall Street targetsJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Crescent Biopharma Inc (CBIO) 財務データ
収益
当期純利益
現金流量
EPS
                大文字化:
                 
                  | 
                ボリューム (24 時間):